COA on Every ProductUSP Certified MaterialsProudly Canadian ManufacturerAll Excipients: USP-Grade ◆ Low Endotoxin ◆ Low MetalRaw Materials Sourced from GMP-Manufacturing FacilitiesCOA on Every ProductUSP Certified MaterialsProudly Canadian ManufacturerAll Excipients: USP-Grade ◆ Low Endotoxin ◆ Low MetalRaw Materials Sourced from GMP-Manufacturing Facilities
GLP2TR
GLP2TR - Image 2
GLP2TR - Image 3
GLP2TR - Image 4

GLP2TR

A research incretin-mimetic peptide (GLP-1 / GIP receptor pathways) for metabolic studies, available in multiple strengths. For research purposes only.

🇨🇦 Canadian First Lyfe is the first manufacturer of dual chamber pens in Canada. Learn More →

Description

GLP2TR is a research incretin-mimetic peptide that acts on both GLP-1 and GIP receptor pathways, a dual-receptor class of high interest in metabolic science.

Commonly explored in research for:

  • Glucose and insulin regulation models
  • Appetite, satiety and energy-intake research
  • Body-composition and adiposity models
  • Dual incretin-receptor (GLP-1 / GIP) signalling

Available in multiple strengths as lyophilized powder; also available in the Lyfe pen.

Related products